BRAND-NEW-GALAXY
17.2.2021 07:02:05 CET | Business Wire | Press release
The rapidly growing global marketing and technology company, Brand New Galaxy launches their Western European Operation in Amsterdam, The Netherlands. The group’s mission is to provide highly specialized and data optimized solutions in E-commerce, Creative & Content Production, and Automation & Performance Improvement from the Dutch capital. Award-winning global marketing and advertising leader, Frank Carvalho is driving the growth of the new operation as Managing Director.
“Our mission is growth. We are growing rapidly, because we are built to drive performance via highly specialized and data optimized solutions for our clients. We deliver growth by utilizing our unique digital offerings and our global network of companies specialized in E-commerce, Creative & Content Production, and Automation & Performance Improvement. We set up our new office in Amsterdam, because the Dutch capital is growing too, becoming the new commercial hub of Europe,” says Frank Carvalho, Managing Director, Brand New Galaxy Amsterdam.
The award-winning Brand New Galaxy is a global provider of end-to-end E-commerce solutions and content production. The company offers several unique methodologies, including Robonauts Pictures E-commerce Real Feel, using production twists that makes online consumers’ product experience comparable to a physical one. Another specialized solution is their FMCC - Fast Moving Consumer Communications method that delivers a quick and scalable content production solution. Part of Brand New Galaxy’s proprietary tools is Synthrone, a modular and flexible ecosystem of automated services for content storage, creation, localization, publishing, tracking, and reporting.
“Efficient management of the entire digital ecosystem is a priority for all businesses who are looking for ways to drive their solid growth in E-commerce. Therefore, as an end-to-end E-commerce player founded on global-to-local methodology we see closer cooperation with our customers in Western Europe as a must have. Our Amsterdam office is a natural consequence of building convenient hubs for well-developed clients and those who are at the early stage of their E-commerce journey,” says Michał Glapiński, Chief Growth Officer responsible for international operations of Brand New Galaxy.
Galactic Growth
Brand New Galaxy has been growing rapidly in the last couple of years by opening new offices and acquiring new companies. Just in 2020 the group launched three offices on three continents, including the United States, the Middle East and Europe. Last year their workforce increased by almost 35 percent to more than 500 employees, with 80 percent of the professionals are working on global and regional levels. They supply global and local services to over 200 clients in 29 languages, from Fortune 500 companies to E-commerce players from small-to-medium-sized businesses. Brand New Galaxy is a three-time winner of the prestigious Press Magazine Awards.
Galactic Talent
Brand New Galaxy’s new Western European operation has a truly global leader. Frank Carvalho, Managing Director has more than 25 years of experience in marketing and advertising from all over the World, including the United States, the United Kingdom, Germany, Poland, Hungary and Australia. He is moving to Amsterdam from New York City, where he was the leader of Account Management in North America and a Global Businesses Director at Hogarth, part of WPP. Some other highlights of his multi-decade career include spending 15 years with the Publicis Groupe as Regional Client Services Director and European Business Lead on Samsung; and being the Senior Brand and Marketing Director at Vodafone in Czech Republic. He has extensive experience in the financial, professional services, pharmaceutical, tobacco, automotive, telecommunications and media sector. He is the winner of four Cannes Lions Awards.
About Brand New Galaxy
Brand New Galaxy is a fast-growing, independent holding of marketing and technology agencies. The privately-owned “independent marketing platform” was founded in Warsaw, Poland in 2017 and has grown to 500+ employees to date. Brand New Galaxy invests in innovative and dynamic ideas that thrive in a start-up environment and are scalable to compete with network agencies. Brand New Galaxy is a member of the MDC Global Affiliates program. Named “Debut of the Year 2018”, “Success of the Year 2019”, “Success of the Year 2020” BNG scores first places in a prestigious agency ranking by PRESS magazine.
Brand New Galaxy companies include:
Pathfinder 23 – global E-commerce agency; Life on Mars – beauty & fashion production agency; Spacecamp – global digital agency; Synthrone - E-commerce automation and implementation platform; Voyager - E-business delivery agency; New Gravity - software & direct-to- consumer house; Robonauts Pictures - E-commerce production house; content26 - Amazon content & advertising, Man on the Moon - HR Agency; BNG MEA – Dubai based hub driving commerce in MEA region; Brand New Galaxy AMS – Amsterdam based hub igniting growth for businesses in Western Europe.
More information:
Web: ams.brandnewgalaxy.com
Downloads: BNG AMS MEDIA
View source version on businesswire.com: https://www.businesswire.com/news/home/20210216006090/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom